rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
2010-11-30
|
pubmed:abstractText |
Advanced esophagogastric carcinoma has a poor prognosis. Palliative chemotherapy provides a survival advantage and improved quality of life. Epirubicin, cisplatin and continuous infusional 5-fluorouracil (5-FU) (ECF) is a well-established chemotherapy regimen but a continuous chemotherapy infusion is not always feasible or acceptable.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1743-7563
|
pubmed:author |
|
pubmed:copyrightInfo |
© 2010 Blackwell Publishing Asia Pty Ltd.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
298-305
|
pubmed:meshHeading |
pubmed-meshheading:21114780-Adenocarcinoma,
pubmed-meshheading:21114780-Aged,
pubmed-meshheading:21114780-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:21114780-Carcinoma, Squamous Cell,
pubmed-meshheading:21114780-Cisplatin,
pubmed-meshheading:21114780-Drug Therapy, Combination,
pubmed-meshheading:21114780-Epirubicin,
pubmed-meshheading:21114780-Esophageal Neoplasms,
pubmed-meshheading:21114780-Female,
pubmed-meshheading:21114780-Follow-Up Studies,
pubmed-meshheading:21114780-Humans,
pubmed-meshheading:21114780-Infusions, Intravenous,
pubmed-meshheading:21114780-Leucovorin,
pubmed-meshheading:21114780-Male,
pubmed-meshheading:21114780-Middle Aged,
pubmed-meshheading:21114780-Stomach Neoplasms,
pubmed-meshheading:21114780-Survival Rate,
pubmed-meshheading:21114780-Treatment Outcome,
pubmed-meshheading:21114780-Vitamin B Complex
|
pubmed:year |
2010
|
pubmed:articleTitle |
A phase I and II trial of epirubicin, cisplatin, 24-hour infusion 5 fluorouracil and sodium folinate in patients with advanced esophagogastric carcinomas.
|
pubmed:affiliation |
Department of Medical Oncology, Guy's Hospital, London, UK. c.karapetis@flinders.edu.au
|
pubmed:publicationType |
Journal Article,
Clinical Trial, Phase II,
Clinical Trial, Phase I
|